NovaBridge Biosciences (NBP) Price to Sales (2023)
NovaBridge Biosciences' (NBP) Price to Sales was 0.66 for Q4 2023, up 40.0% from the prior quarter.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Price to Sales (2023) Analysis & Trends
For FY2023, Price to Sales at NovaBridge Biosciences was 242.62, up 8.5% from FY2022.
- By year, Price to Sales came in at 223.66 in FY2022 (-18.4%), 274.21 in FY2021 and 14.30 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | NovaBridge Biosciences | 99.23 Mn | -696.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 0.66 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 1.06 |
API Access
NovaBridge Biosciences Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();